BDSX vs. EUDA, NAKA, KDLY, QIPT, ATPC, OPGN, PIII, BNR, BMGL, and CCM
Should you be buying Biodesix stock or one of its competitors? The main competitors of Biodesix include EUDA Health (EUDA), KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Agape ATP (ATPC), OpGen (OPGN), P3 Health Partners (PIII), Burning Rock Biotech (BNR), Basel Medical Group (BMGL), and Concord Medical Services (CCM). These companies are all part of the "healthcare" industry.
Biodesix vs. Its Competitors
Biodesix (NASDAQ:BDSX) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.
EUDA Health has a net margin of 0.00% compared to Biodesix's net margin of -54.28%. EUDA Health's return on equity of 0.00% beat Biodesix's return on equity.
Biodesix currently has a consensus price target of $1.75, suggesting a potential upside of 534.52%. Given Biodesix's higher probable upside, research analysts plainly believe Biodesix is more favorable than EUDA Health.
21.0% of Biodesix shares are owned by institutional investors. Comparatively, 4.4% of EUDA Health shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, Biodesix's average media sentiment score of 0.00 equaled EUDA Health'saverage media sentiment score.
EUDA Health has lower revenue, but higher earnings than Biodesix.
Biodesix has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500.
Summary
EUDA Health beats Biodesix on 7 of the 13 factors compared between the two stocks.
Get Biodesix News Delivered to You Automatically
Sign up to receive the latest news and ratings for BDSX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BDSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Biodesix Competitors List
Related Companies and Tools
This page (NASDAQ:BDSX) was last updated on 7/7/2025 by MarketBeat.com Staff
